Western Australian Drug Evaluation Panel - WADEP

Members of WADEP


Name Surname Position Title Service Area
Richard WOJNAR-HORTON (Chairman)
Chief Pharmacist
Pharmacy, Fremantle Hospital
Joel HEEG Senior Pharmacist Pharmacy, Sir Charles Gairdner Hospital

Audrey

KOAY

Senior Clinical Adviser

WA Department of Health

Ian LAWRANCE Staff Specialist and Senior Lecturer Gastroenterology, Fremantle Hospital & UWA
David McGECHIE Staff Specialist Clinical Microbiology, Fremantle Hospital
Richard HERRMANN Consultant Haematologist Royal Perth Hospital
Mitch MESSER Consumer representative WA Health Consumers Council
Michael MILLWARD Clinical Oncologist Cancer Research, Sir Charles Gairdner Hospital and UWA
Sue MOREY Nurse Practitioner Sir Charles Gairdner Hospital
Elizabeth PHILLIPS Consultant and Clinical Pharmacologist Immunology, Royal Perth & Sir Charles Gairdner Hospitals
Elizabeth ROHWEDDER Senior Project Co-ordinator & Economist WA Department of Health
Frank SANFILIPPO Research Assistant Professor School of Population Health, UWA
Bhajan SINGH Consultant Pulmonary Physiology, Sir Charles Gairdner Hospital
Mark THOMAS Consultant Nephrology, Royal Perth Hospital
James WILLIAMSON Staff Specialist General Medicine, Sir Charles Gairdner Hospital
David LYON (ex officio) Executive Officer, WATAG
Michael PFORR (ex officio) Executive Officer, WADEP

Membership of WADEP is formally composed of four senior clinicians with an interest in drug use, nominated by the Executive Director or other senior executive of each metropolitan teaching hospital; the Chairperson of each adult tertiary hospital's Drug and Therapeutics Committee (by invitation, if not otherwise included); a Chief Pharmacist from one of the adult teaching hospitals, possibly in rotation; a senior pharmacist; a senior nurse; a clinical pharmacologist (by invitation, if not otherwise included); a clinical microbiologist (by invitation, if not otherwise included); a clinical oncologist or haematologist (by invitation, if not otherwise included); a public health physician or health economist with expertise in economic modelling as applied to drugs (by invitation); a consumer advocate with knowledge of medical ethics (by invitation). An Executive Officer is be appointed by WADEP and provides a secretariat function.


Back to Top